DR Congo authorises trial of experimental Ebola vaccine

May 29, 2017
The Ebola virus, isolated in November 2014 from patient blood samples obtained in Mali. The virus was isolated on Vero cells in a BSL-4 suite at Rocky Mountain Laboratories. Credit: NIAID

The Democratic Republic of Congo has approved using an experimental Ebola vaccine to combat an outbreak of the virus in the northeast, the government said Monday.

"The DRC accepts the use of vaccines against the Ebola virus," a source in the told AFP, adding that the government concluded it had no objections to the tests being conducted in the country.

"We're waiting for an operational plan from our partners which will determine what steps need to be taken, in which geographic areas we could vaccinate," the source added, on condition of anonymity.

A definitive decision on how the vaccine would be deployed will be released in 24 hours, the source said.

There is no licensed vaccine for the Ebola virus, but the World Health Organization said this month that a promising candidate exists and could be deployed within a matter of days if the DR Congo government gave its approval.

On May 12, DR Congo declared an outbreak of the highly contagious disease, the eighth to date in a sprawling country five times the size of France.

A week later, researchers in the United States said they had found antibodies that could be used to neutralise the three main strains of Ebola.

So far, two cases of the virus have been confirmed in a laboratory while 18 others are suspected in the remote Bas-Uele province, an equatorial forest zone near the Central African Republic.

Three of those people have died, including the first known case, a 39-year-old man who died on the way to hospital in Likati on April 22, suffering from fever, vomiting and bleeding symptoms.

It is the first outbreak of Ebola, which spreads by contact with bodily fluids, since the west Africa epidemic that ended in January last year after killing more than 11,300 people and sickening nearly 29,000.

Explore further: WHO eyes vaccine trial for Ebola-hit DR Congo

Related Stories

WHO eyes vaccine trial for Ebola-hit DR Congo

May 18, 2017
An unlicensed Ebola vaccine could soon be tested in a remote region of the Democratic Republic of Congo hit by an outbreak of the virus, the World Health Organization said Thursday.

WHO: 400 contacts being traced in Congo's Ebola outbreak

May 18, 2017
Health workers are monitoring more than 400 people amid an Ebola outbreak in a remote corner of Congo where already three deaths have been blamed on the virus, the World Health Organization said Thursday.

No need for travel restrictions in Congo Ebola outbreak, WHO says

May 14, 2017
An Ebola outbreak in Congo appears to be limited to a remote area, making travel or trade restrictions unnecessary for the time being, the World Health Organization said Saturday.

Congo announces 9 suspected Ebola cases, including 3 deaths

May 12, 2017
One person has been confirmed dead from Ebola in an outbreak in a remote corner of northern Congo as health authorities look into a total of nine suspected cases, including two other deaths, the country's health minister ...

Number of suspected Ebola cases in Congo now up to 29

May 19, 2017
The World Health Organization says Congo now faces 29 suspected cases of the deadly Ebola virus.

Ebola outbreak in remote part of DR Congo

May 12, 2017
The first Ebola outbreak since the crisis in West Africa that killed 11,300 people has been declared in northeast Democratic Republic of Congo, the World Health Organization said Friday, after the virus caused three deaths ...

Recommended for you

Breakthrough in designing a better Salmonella vaccine

September 24, 2018
UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection—a critical step in developing ...

Antifungal agent found to be possible treatment for porphyria

September 24, 2018
A large team of researchers from Spain, France and the U.S. has found that a common antifungal agent might be useful as a treatment for a rare type of porphyria. In their paper published in the journal Science Translational ...

New findings on the muscle disease Laing early-onset distal myopathy

September 24, 2018
New avenues are now being opened toward treatment of Laing distal myopathy, a rare disorder that causes atrophy of the muscles in the feet, hands and elsewhere. In a study published in the journal PNAS, researchers have identified ...

Insulin shows great potential against chronic colitis

September 24, 2018
Diabetes is not the only disease on which insulin has an effect, it appears. In a new study using tests on mice, researchers from the University of Copenhagen, among others, have discovered a new method for treating chronic ...

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.